
Auteur G. BERSANI
|
Documents disponibles écrits par cet auteur (4)

G. VALERIANI ; O. CORAZZA ; F. S. BERSANI ; C. MELCORE ; A. METASTASIO ; G. BERSANI ; F. SCHIFANO | 2015
Dans Human Psychopharmacology: Clinical and Experimental (Vol.30, n°4, July 2015) Article : PériodiqueENGLISH: Objective: The pharmacological self-management of novel psychoactive substance (NPS)-induced psychopathological consequences represents a fast growing phenomenon. This is facilitated by the frequent sharing of NPS intake experiences on[...]
O. CORAZZA ; G. VALERIANI ; F. S. BERSANI ; J. CORKERY ; G. MARTINOTTI ; G. BERSANI ; F. SCHIFANO | 2014
Dans Journal of Psychoactive Drugs (Vol.46, n°4, September-October 2014) Article : PériodiqueIntroduction: Novel Psychoactive Substances (NPSs) are often sold online as "legal" and "safer" alternatives to International Controlled Drugs (ICDs) with captivating marketing strategies. Our aim was to review and summarize such strategies in t[...]![]()
R. RINALDI ; G. BERSANI ; E. MARINELLI ; S. ZAAMI | 2020
Dans Human Psychopharmacology: Clinical and Experimental (Vol.35, n°3, May 2020) Article : PériodiqueThe ever-growing number of novel psychoactive substances (NPS) that have been surfacing globally, as well as related changes in drug abuse trends, undoubtedly constitute a difficult and multifaceted challenge for psychiatry. The intake and abuse[...]